CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 26 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2013 | $416,000 | – | 97,688 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,632,259 | $628,000 | 0.03% |
| CONDOR CAPITAL MANAGEMENT | 10,000 | $4,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 17,500 | $7,000 | 0.00% |
| Krilogy Financial LLC | 600 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 934 | $0 | 0.00% |
| NORTHERN TRUST CORP | 33,166 | $13,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 86,456 | $33,000 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,900 | $9,000 | 0.00% |
| CITIGROUP INC | 30 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 106,036 | $41,000 | 0.00% |